Ibuzatrelvir
Catalog No.
BA2267
Ibuzatrelvir (PF-07817883), second-generation oral bioavailability, is a SARS-CoV-2 major protease (and) inhibitor with improved metabolic stability.
Featured Products
Ibuzatrelvir (PF-07817883), second-generation oral bioavailability, is a SARS-CoV-2 major protease (and) inhibitor with improved metabolic stability.Ibuzatrelvir demonstrated pan-human coronavirus antiviral activity and off-target selectivity in in vitro and preclinical animal studies.Ibuzatrelvir was well tolerated and safety profile is favorable and similar to placebo in preventing viral infection and transmission.Ibuzatrelvir can be used to inhibit COVID-19.
Physical Appearance | A solid |
Storage | Tightly sealed and desiccated at 4°C |
M.Wt | 489.49 |
Cas No. | 2755812-39-4 |
Formula | C21H30F3N5O5 |
Synonyms | PF-07817883 |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |